Ulcerative colitis as a progressive disease: the forgotten evidence.
about
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseasesGastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale SurveyIntroducing vedolizumab to clinical practice: who, when, and how?Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.The risks and benefits of early immunosuppression and biological therapy.Deep remission: a new concept?Ulcerative colitis: current pharmacotherapy and future directions.Conventional drug therapy for inflammatory bowel disease.Clinical trials in ulcerative colitis: a historical perspective.The biologics of ulcerative colitis.Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC.Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.Ethnic variations in ulcerative colitis: Experience of an international hospital in ThailandNew tools and approaches for improved management of inflammatory bowel diseases.Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis.Changing treatment paradigms for the management of inflammatory bowel disease.Rectal hypersensitivity in patients with quiescent ulcerative colitis.Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis.A Step Forward in the Understanding of Structural and Functional Bowel Damage in Patients with Ulcerative Colitis.TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal.Ulcerative Colitis: Are We Neglecting Its Progressive Character.
P2860
Q27008246-AE326321-4913-4825-8663-D3CCC421FD8CQ30489693-65AEC945-9469-42D4-89D2-D848F64C3C75Q35562290-076D2C60-FAFA-4669-9DCF-E6B8B8F413DFQ37521805-F51DE9CB-6F89-4C65-B121-FEC70A052AA0Q38072232-17A5A983-0240-4B5D-8598-258D8FCDFC65Q38072233-CFBB1F6F-1A98-435B-9220-76C352FA4B1DQ38217653-495E7DA8-DEFA-41D5-BC5C-AA92E16D51EAQ38293796-7E287ADC-17F6-4A08-AD77-7AAB28754712Q38443024-D832D911-0A7C-4A7C-AAE8-809A0750D682Q39037681-8ADB40C0-E501-4772-949E-2FF69DEBA97EQ39167818-3266D2FA-0FFA-494E-8E9E-7F7EBAAF0869Q39404449-A7812F89-C197-4DB1-A774-34661A8EAF50Q41760220-B7288499-2F95-4AB7-B71D-76D19492E43EQ46511762-788B1343-6F33-4188-A150-8B7F43329D57Q48223667-1A127855-6C54-411B-90D2-150E426C704BQ48537463-64477155-536B-4387-905C-EB3A32276597Q50447218-CF8D9C8D-EF34-4E50-BF45-57ABACCD59F9Q53685676-CC0A4E4E-81B9-402C-B1ED-410002FDCB90Q54965170-880397C4-978A-4746-A618-939433E2D130Q54979996-F67FA17A-5211-4241-BE6A-0BAC9978B1C8Q55043055-D136205F-8C63-4D5D-8BCA-55CCB84B99D4
P2860
Ulcerative colitis as a progressive disease: the forgotten evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ulcerative colitis as a progressive disease: the forgotten evidence.
@en
Ulcerative colitis as a progressive disease: the forgotten evidence.
@nl
type
label
Ulcerative colitis as a progressive disease: the forgotten evidence.
@en
Ulcerative colitis as a progressive disease: the forgotten evidence.
@nl
prefLabel
Ulcerative colitis as a progressive disease: the forgotten evidence.
@en
Ulcerative colitis as a progressive disease: the forgotten evidence.
@nl
P2093
P2860
P356
P1476
Ulcerative colitis as a progressive disease: the forgotten evidence.
@en
P2093
David B Sachar
Joana Torres
Vincent Billioud
P2860
P304
P356
10.1002/IBD.22839
P577
2011-12-11T00:00:00Z